C83.76 Burkitt lymphoma, intrapelvic lymph nodes

Name of the Condition

• Burkitt lymphoma, intrapelvic lymph nodes
• Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. This subtype involves the lymph nodes located within the pelvic region. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

• Epstein-Barr virus (EBV) infection
• Human immunodeficiency virus (HIV) infection
• Weakened immune system from other conditions or treatments
• Young age, especially in children and young adults
• Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

• Rapidly growing, painless lymph node swelling in the pelvic area
• Abdominal or pelvic pain
• Bloating or fullness in the abdomen
• Fever
• Night sweats
• Unexplained weight loss
• Fatigue

Diagnosis

Diagnosis involves a physical examination to assess lymph node or organ swelling, followed by imaging tests (e.g., CT or MRI) to identify tumor locations. A biopsy of affected tissue is performed to confirm the presence of cancerous cells and determine the specific subtype. Additional tests, such as blood work or bone marrow biopsy, may be used to stage the disease and assess overall health.

Treatment Options

Treatment typically involves intensive chemotherapy regimens, often including combinations of multiple drugs. For localized disease, radiation therapy may be used. In some cases, targeted therapies or immunotherapy may be considered. Treatment plans are tailored to the patient's age, overall health, and disease stage.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for Burkitt lymphoma can be favorable, especially in younger patients. However, the aggressive nature of the disease requires close monitoring. Follow-up care includes regular imaging and blood tests to check for recurrence. Long-term survivors may require ongoing surveillance for late effects of treatment.

Complications

• Tumor lysis syndrome (due to rapid cell death during treatment)
• Infection risk from weakened immune system
• Organ damage from tumor growth or treatment side effects
• Recurrence of lymphoma

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known risk factors, such as unprotected exposure to EBV (where applicable).
• Follow recommended cancer screening guidelines, especially if at higher risk.
• Discuss vaccination status with a healthcare provider, as some vaccines may be beneficial.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Rapidly enlarging lymph nodes in the pelvic area
• Persistent abdominal or pelvic pain
• Unexplained weight loss or fever
• Fatigue that interferes with daily activities

Tips for Medical Coders

When coding for Burkitt lymphoma involving intrapelvic lymph nodes, use code C83.76. Ensure documentation specifies the anatomical location (intrapelvic lymph nodes) to support accurate code assignment. Verify that the diagnosis aligns with clinical findings and that any relevant staging or treatment details are clearly documented.